Vanguard Personalized Indexing Management, LLC Intellia Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,277 shares of NTLA stock, worth $287,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,277
Previous 11,208
8.31%
Holding current value
$287,550
Previous $79,000
21.52%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NTLA
# of Institutions
338Shares Held
96.9MCall Options Held
1.66MPut Options Held
1.03M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$364 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$304 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$269 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.12MShares$115 Million0.0% of portfolio
-
State Street Corp Boston, MA4.04MShares$113 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $2.13B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...